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ABSTRACT
Background: This study aimed to determine: (1) the prevalence of depression, anxiety, and depression
associated with anxiety (DA); (2) the risk factor profile of depression, anxiety, and DA; (3) the course of
depression, anxiety, and DA over 24 months.
Methods: Two-year longitudinal study of 20,036 adults aged 60+ years. We used the Patient Health
Questionnaire and the Hospital Anxiety and Depression Scale anxiety subscale to establish the presence of
depression and anxiety, and standard procedures to collect demographic, lifestyle, psychosocial, and clinical
data.
Results: The prevalence of anxiety, depression, and DA was 4.7%, 1.4%, and 1.8%. About 57% of depression
cases showed evidence of comorbid anxiety, while only 28% of those with clinically significant anxiety had
concurrent depression. There was not only an overlap in the distribution of risk factors in these diagnostic
groups but also differences. We found that 31%, 23%, and 35% of older adults with anxiety, depression, and
DA showed persistence of symptoms after two years. Repeated anxiety was more common in women and
repeated depression in men. Socioeconomic stressors were common in repeated DA.
Conclusions: Clinically significant anxiety and depression are distinct conditions that frequently coexist in later
life; when they appear together, older adults endure a more chronic course of illness.
Key words:mood disorder, anxiety disorder, mixed state, elderly, prognosis, epidemiology
Introduction
Depression and anxiety are disabling disorders that
affect people of all ages (Lindesay et al., 1989;
Steffens and McQuoid, 2005; Prince et al., 2007;
Almeida et al., 2010). There is evidence that
they share risk factors in later life, and that the
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overlap between these two conditions may be more
than coincidental (Gale et al., 2011). British data
showed that the distribution of age, education,
social class, disability, and living arrangements is
similar in older people with depression and anxiety
(Kvaal et al., 2008), while Dutch findings revealed
that nearly half of older people with depression
fulfill criteria for a concurrent anxiety disorder
(Beekman et al., 2000). Such an overlap has led
some investigators to suggest that depression and
anxiety may not be discrete disorders in later life,
representing instead phenotypical expressions of the
same condition along a continuum (Schoevers et al.,
2005).
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Kendell and Jablensky suggested that the use
of structured criteria enhances the reliability of
psychiatric diagnoses, although this does not mean
that these are, by consequence, valid or useful
(Kendell and Jablensky, 2003). They argued that
a valid clinical diagnosis is characterized by “zones
of rarity” that set them apart from normality and
from other medical illnesses in terms of signs
and symptoms, pathophysiology, and etiology. In
contrast, the usefulness of a diagnosis is largely
based on its ability to predict response to treatment
and prognosis over time. Hence, if depression
and anxiety are distinct disorders, one might
expect minimal overlap between them. In addition,
they would show easily distinguishable risk factor
profiles and well-delineated courses over time. An
alternative way of thinking about this is that similar
conditions must share risk factors and natural
history, although commonality of factors may not be
sufficient to guarantee that two apparently distinct
conditions are but one. Moreover, because of the
large number of risk factors associated with these
conditions in later life (Pirkis et al., 2009; Almeida
et al., 2011), investigating such associations is
only possible by means of large longitudinal
surveys.
We used data gathered as part of a study of over
20,000 community dwelling older Australians to
determine: (1) the point prevalence of depression,
anxiety, and of depression associated with anxiety
(DA); (2) the risk factor profile of depression,
anxiety, and DA; and (3) the course of depression,
anxiety, and DA over 24 months.
Methods
Study design and participants
The present analyses are based on data originating
from the Depression and Early Prevention
of Suicide in General Practice (DEPS-GP)
study, a clustered randomized trial that was
originally designed to investigate how a GP-
centered intervention changed the prevalence of
depression among their patients. Details regarding
the recruitment have been reported elsewhere
(Williamson et al., 2007; Almeida et al., 2011).
Between May and December 2005, each patient
aged 60 years or over of participating primary
care practices was sent a questionnaire. We asked
potential participants to return the questionnaires
(blank in the case of non-consenting subjects)
so that we could estimate the true denominator
of the target population. We received 22,258
questionnaires with written informed consent.
Another 9,087 questionnaires were returned not
completed, 2,934 were returned to the sender
because the person named on the envelope was
not known at the address, and 820 failed to be
posted (total number of questionnaires tracked:
35,099). A small number of older adults who
consented were found to be ineligible because
they were under 60 years of age (n= 120) or
did not reside in the community (nursing home
n= 54), while a further 243 had incomplete data
on basic demographic characteristics (age and
gender) and were excluded from the analysis,
leaving a sample of 21,841 older people, of whom
20,036 reported information on depressive and
anxiety symptoms. The Ethics Committees of the
University of Western Australia, the University
of Melbourne, and the Royal Australian College
of General Practitioners approved the study
protocol and all participants provided informed
consent.
Outcomes of interest
The outcomes of interest in this study were major
depressive symptoms, clinically significant anxiety
symptoms, or comorbid major depressive and
anxiety symptoms.
We used the Patient Health Questionnaire
(PHQ-9) to assess depression (Kroenke et al.,
2001) and a validated algorithm to establish the
presence of major depressive symptoms according
to DSM-IV criteria (Spitzer et al., 1999). The
PHQ-9 consists of nine questions about how often
the respondent has been bothered by depressive
symptoms during the past two weeks, each of
which is scored from 0 to 3. To meet criteria for
depression, the respondent had to score at least 2 on
one of the first two questions of the PHQ-9 (items
“a” or “b” below). In addition, he or she should
have experienced at least five of the nine symptoms
described in the PHQ-9 for most days during the
same two-week period: (a) decreased interest or
pleasure; (b) low mood; (c) sleep disturbance; (d)
lack of energy; (e) disturbed appetite; (f) feelings
of failure or guilt; (g) poor concentration; (h)
psychomotor disturbance; and (i) suicidal thoughts.
We measured anxiety symptoms with the anxiety
subscale of the Hospital Anxiety and Depression
Scale (HADS-A) (Zigmond and Snaith, 1983;
Bjelland et al., 2002). Possible scores range from
0 to 21, with scores of 11 or greater indicating the
presence of clinically significant anxiety (Zigmond
and Snaith, 1983). Each of the following items
is scored on a scale that ranges from 0 to 3:
feeling tense or wound up, feeling frightened as
if something awful is about to happen, worrying
thoughts, inability to sit at ease or relax, feelings
of “butterflies’” in stomach, restlessness, sudden
feelings of panic.
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Other study measures
Participantsprovided information about their
gender, place of birth (Australia vs. overseas),
marital status, highest educational achievement,
and date of birth, which we used to calculate their
age (in years). We also asked participants if, as a
rule, they did at least half an hour of moderate
or vigorous exercise on five or more days of the
week (yes/no) (Elley et al., 2003), if they smoked
(never, past, current), and how many standard
drinks they normally had on each typical day of the
week. People who reported consuming seven or
more drinks on any one day or who had three or
more drinks nearly every day were considered risk
drinkers (NHMRC, 2009).We used self-reported
height and weight to calculate the body mass index
(BMI) in Kg/m2, and classified as overweight or
obese participants with BMI ≥ 25. We collected
information about living arrangements (alone vs.
with others) and used the Duke Social Support
Index (DSSI) to measure perceived social support
(Koenig et al., 1993). DSSI scores≤ 31 represented
the lowest quartile of scores in our sample and were
used as an indicator of poor social support. Older
adults in the lowest quintile of the Index of Relative
Socio-Economic Disadvantage were considered
socially disadvantaged (Pink, 2008).In addition,
participants indicated whether they attended
religious services regularly (yes/no) and whether
they were experiencing financial strain (distinctly or
very much vs. slightly or not at all). They recorded
(yes/no) whether they had lost a parent or had been
victims of physical or sexual abuse before they were
aged 15 years (“Were you the victim of physical
or sexual abuse before you were 15 years old?”)
(Draper et al., 2008), and rated their overall health
(fair/poor compared with good to excellent), their
experience of pain (not at all or a little vs. quite
a bit to extreme pain that interfered with work
during the preceding four weeks) (the latter two
questions are part of the Health Survey SF-12)
(Ware et al., 2002), and reported whether they had
been advised by their doctor that they had had
depression, anxiety, diabetes, hypertension, a heart
attack, or a stroke (i.e., doctor-made diagnosis).
Procedures for the collection of endpoints
Consenting participants completed the self-rating
postal questionnaire at baseline and after 24
months. We used these two assessments to
determine the proportion of participants who
fulfilled the study criteria for the diagnosis of anxiety
at baseline and 24 months (persisting anxiety),
depression at baseline and 24 months (persisting
depression), or both anxiety and depression at
baseline and 24 months (persisting anxiety plus
depression).
Between the baseline and 24-month assessment,
the GPs of participants were randomly assigned to
a control group or to an educational intervention
that consisted of three components: (1) printed
educational material about the assessment and
management of depression and self-harm behavior
in later life, (2) detailed feedback on up to 20
practice audits, and (3) educational newsletters
posted 6, 12, and 18 months after recruitment.
The control group did not receive educational
material nor did they receive detailed individualized
feedback for their practice audits.
Statistical analysis
Data were managed and analyzed with Stata
software version 12.0 (StataCorp, College Station,
TX, USA, 2011). We used descriptive statistics
to summarize the data and cross-tabulation to
determine their distribution according to depression
status. Participants were divided into four groups
according to the results of their PHQ-9 and
HADS-A ratings at the baseline assessment:
no depression or anxiety, depression, anxiety
(HADS-A≥11), depression and anxiety (DA).
We then investigated the association between
measured factors (independent variables) and
the clinical groupings (dependent variable) using
multinomial logistic regression (command: mlogit),
with those participants without depression or
anxiety representing the reference group. The
reported odds ratio (OR) and respective 95%
confidence interval of the OR (95% CI) were
derived from a multivariate model that included
all measured factors. The models were checked
for goodness of fit using the Pearson goodness-of-
fit test. We also calculated the OR of depression,
anxiety, DA, and loss to follow up at the
24-month assessment according to the clinical
status of participants at baseline. We included all
demographic, lifestyle, socioeconomic, and clinical
factors in the multivariate model, which was further
adjusted for the participation of treating GPs in the
educational activity.
Finally, we created clinical groups of repeated
anxiety (HADS-A≥11 at baseline and at the 24-
month assessment), repeated depression (depres-
sion at baseline and at the 24-month assessment),
and repeated DA (HADS-A≥11 and depression
at the baseline and at the 24-month assessment).
Again, we applied multinomial multivariate logistic
regression to estimate the OR of these clinical
groupings according to baseline exposures, and took
into account in the analyses the participation of GPs
in the educational activities about depression and
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self-harm. Alpha was set at 5% and all probability
tests used were two-tailed.
Results
The study sample consisted of 20,036 participants:
936 (4.7%) had anxiety but no depression, 275
(1.4%) had depression but not anxiety, and
360 (1.8%) showed evidence of both at the
baseline assessment. Their demographic, lifestyle,
socioeconomic, and clinical characteristics of
participants are summarized in Table 1. The
prevalence of anxiety was highest among the
youngest older adults (aged 60–64 years) and
lowest amongst the oldest old (aged over 85 years).
A similar distribution pattern was observed for
comorbid DA, but such an association was not
significant for depression. The odds of anxiety
were comparatively higher in women, migrants,
people without higher education, those who were
physically inactive or used alcohol at risky levels,
participants in the lowest quintile of social support
or who were experiencing financial strain, and those
who reported they had been victims of physical
abuse during childhood. Anxiety was more frequent
among participants with past history of anxiety
and depression, concurrent pain, or poor self-
perceived health. In contrast, the prevalence of
anxiety was comparatively lower among people
who were overweight/obese or who reported having
diabetes. Finally, the use of benzodiazepines
and antidepressants was higher among those
with anxiety than those without anxiety or
depression.
Demographic and lifestyle variables showed no
marked association with depression at baseline
(Table 1), although poor social support, financial
strain, history of depression, pain, poor perceived
health, and diabetes did. Apart from the latter,
there was no evidence that vascular risk factors were
associated with depression. In addition, participants
with depression were more frequent users of
benzodiazepines and of antidepressants than people
without anxiety or depression.
The distribution of demographic, lifestyle,
socioeconomic, and clinical variables among
participants with DA at baseline was very similar
to that observed for people with anxiety alone,
except that current smoking increased and non-risk
alcohol use decreased the odds of DA. Moreover,
the association between poor social support and DA
was particularly strong, as was past depression. The
odds of DA were higher among benzodiazepine and
antidepressant users.
We then used multinomial logistic regression
to calculate the odds of anxiety, depression,
and comorbid DA at the 24-month assessment
according to the clinical status of participants at
the time of entry into the study. The results of
these analyses are summarized in Table 2. We
found that the presence of anxiety at baseline
increased the odds of anxiety, depression, DA,
and loss to follow up by 24 months. The same
pattern was observed for baseline depression and
for comorbid DA. We also found baseline anxiety
was more strongly associated with follow-up anxiety
and comorbid DA than with depression, whereas
baseline depression was more strongly associated
with follow-up depression, followed by comorbid
DA and, finally, anxiety. Baseline DA was strongly
associated with follow-up DA, followed by anxiety
and then depression. Participants who showed
evidence of comorbid DA at baseline were 4.5
(95% CI= 3.1–6.6) times more likely than those
without anxiety or depression to be lost to follow-
up. Supplementary table S1 (available online)
shows the demographic, lifestyle, socioeconomic,
and clinical characteristics of participants at the
baseline assessment according to whether or not
they were available for follow-up. Patients of GPs
who took part in the educational activity about
depression and self-harm behavior in later life had
10% (95% CI= 0–20%) lower odds of being lost
during follow-up.
Finally, we investigated the association between
baseline measures and repeated anxiety, repeated
depression, and repeated DA. The results of these
analyses are summarized in Table 3. Women had
greater odds of presenting with repeated anxiety,
but the opposite occurred for repeated depression.
Those without postschool education or who were
married were also more likely to present with
repeated anxiety, but these factors showed no
apparent association with repeated depression or
with repeated DA. Poor social support increased
the odds of repeated anxiety, repeated depression,
and of repeated DA, whereas living alone increased
the odds of repeated depression. Financial strain
increased the odds of both repeated anxiety and
of repeated DA, but not of repeated depression.
In contrast, history of childhood physical abuse
increased the odds of repeated depression, but not
of repeated anxiety or comorbid DA. History of
anxiety or depression before the baseline assessment
increased the odds of repeated anxiety and of
repeated DA, but not of repeated depression.
A similar distribution pattern was observed for
baseline pain. Poor self-perceived health increased
the odds of repeated anxiety, repeated depression,
and repeated DA. Finally, diabetes at baseline
increased the odds of repeated depression at follow-
up, but not of repeated anxiety or of comorbid
DA.
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Table 1. Demographic, lifestyle, social, and clinical characteristics of participants with clinically significant
symptoms of anxiety, major depression, and both
SAMPLE ANXIETY DEPRESSION DEPRESSION &
N = 20,036 N = 936 n (%) N = 275 n (%) ANXIETY N = 360
n (%) OR [95% CI] OR [95% CI] n (%) OR [95% CI]
...............................................................................................................................................................................................................................................................................................................
Demographic information
Age (in years) 60–64 4,217 (21.0) 297 (31.7) 66 (24.0) 117 (32.5)
1 1 1
65–69 4,793 (23.9) 230 (24.6) 50 (18.2) 88 (24.4)
0.7 [0.6–0.9] 0.7 [0.4–1.0] 0.7 [0.5–1.0]
70–74 4,098 (20.4) 175 (18.7) 43 (15.6) 65 (18.1)
0.6 [0.5–0.8] 0.7 [0.4–1.0] 0.7 [0.5–1.1]
75–79 3,932 (19.6) 128 (13.7) 56 (20.4) 46 (12.8)
0.5 [0.4–0.7] 0.8 [0.5–1.2] 0.6 [0.4–1.0]
80–84 1,997 (10.0) 75 (8.0) 38 (13.8) 32 (8.9)
0.6 [0.4–0.9] 0.9 [0.6–1.6] 0.6 [0.3–1.1]
85+ 999 (5.0) 31 (3.3) 22 (8.0) 12 (3.3)
0.4 [0.2–0.6] 0.9 [0.4–1.7] 0.3 [0.1–0.8]
Female gender 11,724 (58.5) 646 (69.0) 154 (56.0) 212 (59.0)
1.7 [1.4–2.0] 0.9 [0.6–1.2] 1.1 [0.8–1.5]
Migrant 5,093 (25.5) 275 (29.5) 66 (24.0) 105 (29.3)
1.3 [1.1–1.6] 0.9 [0.7–1.3] 1.3 [1.0–1.8]
Not married 6,490 (32.5) 338 (36.3) 116 (42.3) 175 (48.6)
0.9 [0.7–1.1] 1.0 [0.7–1.5] 1.3 [0.9–1.8]
No postschool education 16,708 (85.1) 809 (88.6) 233 (86.6) 322 (92.8)
1.6 [1.2–2.0] 1.1 [0.7–1.7] 2.1 [1.3–3.4]
Lifestyle variables
Physically inactive 7,317 (36.9) 445 (47.9) 154 (56.4) 202 (56.9)
1.2 [1.0–1.4] 1.3 [1.0–1.7] 1.5 [1.1–2.0]
Overweight or obese 11,875 (64.5) 552 (64.9) 170 (69.7) 238 (73.9)
0.8 [0.7–1.0] 0.8 [0.6–1.2] 1.2 [0.8–1.5]
Smoking Never 10,305 (52.0) 435 (46.8) 130 (47.4) 125 (34.8)
1 1 1
Past 8,367 (42.0) 386 (41.5) 117 (42.7) 153 (42.6)
0.9 [0.8–1.2] 0.9 [0.6–1.2] 1.1 [0.8–1.5]
Current 1,260 (6.3) 108 (11.6) 27 (9.8) 81 (22.6)
1.0 [0.8–1.4] 1.1 [0.6–1.8] 2.3 [1.5–3.5]
Alcohol use None 4,857 (24.5) 258 (28.0) 95 (35.1) 127 (35.9)
1 1 1
Non-risk use 12,442 (62.7) 524 (57.0) 145 (53.5) 167 (47.2)
1.0 [0.8–1.2] 0.8 [0.5–1.0] 0.7 [0.5–0.9]
Risk use 2,546 (12.8) 138 (15.0) 31 (11.4) 60 (16.9)
1.4 [1.0–1.8] 0.7 [0.4–1.2] 0.9 [0.6–1.5]
Socioeconomic history
Living alone 4,735 (23.7) 220 (23.7) 72 (26.2) 110 (30.6)
0.9 [0.7–1.2] 1.2 [0.8–1.8] 1.0 [0.7–1.5]
Poor social support 3,912 (20.1) 453 (49.9) 148 (56.1) 263 (75.8)
2.8 [2.4–3.4] 3.9 [2.9–5.3] 7.6 [5.5–10.5]
Social disadvantage 3,958 (19.7) 206 (22.0) 69 (25.1) 92 (25.6)
1.1 [0.9–1.3] 1.2 [0.9–1.7] 1.2 [0.9–1.7]
No religion practice 10,800 (54.2) 500 (53.6) 165 (60.2) 209 (58.2)
0.9 [0.8–1.1] 1.3 [0.9–1.7] 0.9 [0.7–1.3]
Financial strain 2,028 (10.5) 242 (27.0) 63 (24.4) 147 (42.5)
2.2 [1.8–2.7] 1.7 [1.2–2.4] 2.7 [2.0–3.7]
Loss of a parent during
childhood
2,526 (12.7) 145 (15.6) 34 (12.5) 55 (15.5)
1.2 [0.9–1.5] 0.9 [0.6–1.3] 1.2 [0.9–1.8]
Childhood physical
abuse
1,343 (6.8) 168 (18.1) 30 (11.1) 86 (24.2)
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Table 1. Continued
SAMPLE ANXIETY DEPRESSION DEPRESSION &
N = 20,036 N = 936 n (%) N = 275 n (%) ANXIETY N = 360
n (%) OR [95% CI] OR [95% CI] n (%) OR [95% CI]
...................................................................................................................................................................................................................................................................................................................
1.6 [1.2–2.1] 1.0 [0.6–1.8] 1.4 [1.0–2.1]
Childhood sexual abuse 1,311 (6.6) 149 (16.1) 28 (10.4) 66 (18.5)
1.2 [0.9–1.5] 1.1 [0.6–1.8] 1.1 [0.7–1.7]
Clinical
Past anxiety disorder 1,863 (9.3) 330 (35.3) 38 (13.8) 171 (47.5)
3.5 [2.9–4.2] 0.7 [0.5–1.2] 3.6 [2.7–4.9]
Past depressive disorder 3,546 (17.7) 504 (53.8) 141 (51.3) 275 (76.4)
2.8 [2.4–3.4] 3.6 [2.6–4.8] 6.5 [4.7–9.0]
Pain 6,121 (30.7) 553 (59.5) 184 (67.4) 268 (74.9)
2.0 [1.7–2.4] 1.9 [1.4–2.7] 2.4 [1.7–3.3]
Poor perceived health 4,471 (22.4) 484 (52.0) 186 (68.1) 260 (73.0)
2.3 [1.9–2.8] 3.7 [2.6–5.2] 3.4 [2.5–4.6]
Diabetes 3,240 (16.2) 167 (17.8) 83 (30.2) 85 (23.6)
0.8 [0.6–1.0] 1.5 [1.1–2.1] 1.0 [0.7–1.4]
Hypertension 10,081 (50.3) 495 (52.9) 152 (55.3) 193 (53.6)
0.9 [0.8–1.1] 0.8 [0.6–1.1] 0.8 [0.6–1.0]
Past heart attack 3,474 (17.3) 204 (21.8) 83 (30.2) 96 (26.7)
1.1 [0.9–1.4] 1.3 [0.9–1.8] 0.8 [0.6–1.2]
Past stroke 1,440 (7.2) 95 (10.1) 47 (17.1) 54 (15.0)
0.9 [0.7–1.3] 1.2 [0.8–1.9] 1.4 [0.9–2.1]
Use of benzodiazepines 1,533 (7.6) 196 (20.9) 40 (14.5) 103 (28.6)
3.8 [3.2–4.5]∗ 2.5 [1.8–3.5]∗ 5.8 [4.6–7.3]∗
Use of antidepressants 2,465 (12.3) 307 (32.8) 98 (35.6) 160 (44.4)
4.3 [3.7–4.9]∗ 4.8 [3.8–6.2]∗ 7.0 [5.6–8.6]∗
Reported odds ratio originated from a multivariate logistic regression where all measured factors were entered in the model together.
OR: odds ratio; 95% CI: 95% confidence interval of the odds ratio.
Bold print indicates p< 0.05.
∗Unadjusted OR.
Table 2. Clinical status of participants after 24months of follow-up according to the presence of anxiety, major
depression, or both at the baseline assessment
CLINICAL STATUS AFTER 24 MONTHS
NO ANXIETY ANXIETY DEPRESSION DEPRESSION & LOST
OR DEPRESSION N = 585 N = 224 ANXIETY N = 231 N = 4,171
N = 14,825 n (%) n (%) n (%) n (%) n (%)
STATUS AT BASELINE OR [95% CI] OR [95% CI] OR [95% CI] OR [95% CI] OR [95% CI]
........................................................................................................................................................................................................................................................................................................................
No anxiety or depression 14,274 (96.3) 298 (50.9) 137 (61.2) 77 (33.3) 3,679 (88.2)
1 1 1 1 1
Anxiety 377 (2.5) 204 (34.9) 24 (10.7) 59 (25.5) 272 (6.5)
1 12.1 [9.3–15.7] 2.1 [1.2–3.7] 11.1 [7.1–17.5] 1.9 [1.6–2.3]
Depression 107 (0.7) 19 (3.2) 40 (17.9) 11 (4.8) 98 (2.3)
1 3.9 [2.2–7.1] 10.7 [6.5–17.8] 6.2 [2.8–13.9] 1.9 [1.3–2.6]
Depression & Anxiety 67 (0.4) 64 (10.9) 23 (10.3) 84 (36.4) 122 (2.9)
1 15.1 [9.4–24.5] 8.7 [4.5–16.7] 54.5 [31.4–94.5] 4.5 [3.1–6.6]
OR: odds ratio; 95% CI: 95% confidence interval of the odds ratio. The OR reported were derived from multivariate logistic regression
analyses, with all measured factors forced into the model. The involvement of treating GPs in an educational activity about depression
and self-harm (yes/no) during the follow-up period was also taken into account in the analysis.
Bold print indicates p< 0.05.
1628 O. P. Almeida et al.
Table 3. Adjusted odds ratio of repeated anxiety, major depressive symptoms, and comorbid anxiety & major
depression after 24 months according to demographic, lifestyle, social, and clinical exposures at baseline
REPEATED REPEATED
ANXIETY REPEATED DEPRESSION &
SAMPLE N = 204 DEPRESSION ANXIETY N = 84
N = 15,865 n (%) N = 40 n (%) n (%)
n (%) OR [95% CI] OR [95% CI] OR [95% CI]
...........................................................................................................................................................................................................................................................................................................................
Demographic information
Age (in years): 60–64 3,585 (22.6) 84 (41.2) 10 (25.0) 25 (29.8)
1 1 1
65–69 3,984 (25.1) 45 (22.1) 10 (25.0) 25 (29.8)
0.6 [0.4–1.0] 1.2 [0.5–3.5] 1.2 [0.6–2.4]
70–74 3,379 (21.3) 40 (19.6) 5 (12.5) 20 (23.8)
0.7 [0.4–1.1] 0.4 [0.1–1.6] 1.4 [0.7–3.0]
75–79 3,001 (18.9) 21 (10.3) 8 (20.0) 10 (11.9)
0.4 [0.2–0.7] 0.9 [0.3–2.8] 0.8 [0.3–2.0]
80–84 1,358 (8.6) 7 (3.4) 5 (12.5) 4 (4.8)
0.4 [0.2–0.9] 1.1 [0.2–4.6] 0.9 [0.2–3.2]
85+ 561 (3.5) 7 (3.4) 2 (5.0) 0
0.7 [0.2–2.0] 0.5 [0.1–4.7] –
Female gender 9,313 (58.7) 155 (76.0) 19 (47.5) 50 (60.2)
2.6 [1.7–3.8] 0.4 [0.6–0.8] 1.1 [0.6–2.0]
Migrant 3,978 (25.2) 54 (26.5) 16 (40.0) 23 (27.7)
1.2 [0.8–1.7] 1.5 [0.7–3.2] 1.1 [0.6–2.0]
Not married 4,789 (30.3) 54 (26.5) 20 (50.0) 38 (45.2)
0.5 [0.3–0.9] 1.2 [0.4–3.6] 1.1 [0.5–2.2]
No postschool education 13,064 (83.8) 175 (88.4) 32 (80.0) 69 (87.3)
1.6 [1.0–2.7] 0.7 [0.3–1.8] 0.8 [0.4–1.7]
Lifestyle variables
Physically inactive 5,584 (35.6) 88 (43.3) 21 (52.5) 49 (59.8)
1.0 [0.7–1.4] 1.1 [0.5–2.4] 1.6 [0.9–2.7]
Overweight or obese 9,590 (65.2) 212 (64.4) 26 (70.3) 55 (72.4)
0.8 [0.6–1.1] 0.6 [0.2–1.3] 0.9 [0.5–1.6]
Smoking Never 8,351 (52.8) 101 (49.5) 21 (52.5) 36 (43.4)
1 1 1
Past 6,537 (41.4) 85 (41.7) 16 (40.0) 31 (37.3)
1.1 [0.7–1.5] 0.5 [0.2–1.2] 0.8 [0.4–1.5]
Current 917 (5.8) 18 (8.8) 3 (7.5) 16 (19.3)
0.9 [0.5–1.7] 0.6 [0.2–2.4] 1.2 [0.5–2.8]
Alcohol use None 3,575 (22.7) 43 (21.3) 17 (43.6) 29 (35.4)
1 1 1
Non-risk use 10,149 (64.5) 131 (64.8) 21 (53.8) 44 (53.7)
1.4 [0.9–2.1] 0.6 [0.3–1.4] 0.8 [0.5–1.5]
Risk use 2,020 (12.8) 28 (13.9) 1 (2.6) 9 (11.0)
1.8 [1.0–3.2] – 0.6 [0.2–1.6]
Socioeconomic history
Living alone 3,649 (23.1) 42 (20.6) 16 (40.0) 23 (27.4)
1.1 [0.6–1.9] 3.0 [1.0–8.5] 1.0 [0.5–2.1]
Poor social support 2,950 (19.0) 99 (49.5) 25 (64.1) 63 (78.7)
2.7 [1.9–3.7] 4.8 [2.0–11.1] 6.1 [3.2–11.8]
Social disadvantage 1,975 (18.7) 45 (22.1) 9 (22.5) 22 (26.2)
1.2 [0.8–1.8] 1.5 [0.6–3.5] 1.5 [0.8–2.8]
No religion practice 8,580 (54.4) 107 (52.4) 24 (60.0) 46 (54.8)
0.9 [0.7–1.3] 1.8 [0.8–4.1] 1.1 [0.6–2.0]
Financial strain 1,487 (9.6) 48 (24.7) 10 (26.3) 40 (50.0)
1.7 [1.2–2.6] 1.6 [0.7–3.7] 3.8 [2.1–6.7]
Loss of a parent during childhood 1,958 (12.4) 29 (14.3) 6 (15.4) 12 (14.5)
1.1 [0.7–1.7] 0.7 [0.2–2.3] 1.2 [0.6–2.6]
Anxiety, depression, and comorbid anxiety and depression 1629
Table 3. Continued
REPEATED REPEATED
ANXIETY REPEATED DEPRESSION &
SAMPLE N = 204 DEPRESSION ANXIETY N = 84
N = 15,865 n (%) N = 40 n (%) n (%)
n (%) OR [95% CI] OR [95% CI] OR [95% CI]
.............................................................................................................................................................................................................................................................................................................
Childhood physical abuse 1,066 (6.8) 37 (18.3) 10 (25.6) 17 (20.5)
1.2 [0.7–1.9] 4.0 [1.5–10.5] 0.8 [0.4–1.8]
Childhood sexual abuse 1,064 (6.8) 38 (18.7) 4 (10.3) 15 (18.1)
1.4 [0.9–2.2] 0.4 [0.1–1.6] 1.1 [0.5–2.4]
Clinical
Past anxiety disorder 1,398 (8.8) 76 (37.2) 7 (17.5) 45 (53.6)
2.9 [2.1–4.2] 0.9 [0.3–2.7] 2.4 [1.4–4.3]
Past depressive disorder 2,667 (16.8) 111 (54.4) 19 (47.5) 70 (83.3)
2.6 [1.8–3.7] 2.0 [0.9–4.4] 8.7 [4.2–18.2]
Pain 4,520 (28.6) 107 (52.4) 27 (69.2) 68 (80.9)
1.5 [1.0–2.1] 1.8 [0.8–4.2] 2.4 [1.2–4.7]
Poor perceived health 3,039 (19.2) 92 (45.3) 28 (70.0) 63 (75.0)
2.0 [1.4–2.9] 4.5 [1.8–11.0] 2.2 [1.2–4.1]
Diabetes 2,412 (15.2) 36 (17.6) 17 (42.5) 20 (23.8)
1.2 [0.8–1.8] 2.5 [1.1–5.4] 1.5 [0.8–2.8]
Hypertension 7,950 (50.1) 108 (52.9) 25 (62.5) 45 (53.6)
1.0 [0.7–1.4] 0.9 [0.4–2.1] 0.6 [0.4–1.2]
Past heart attack 2,536 (16.0) 27 (13.2) 11 (27.5) 25 (29.8)
0.7 [0.4–1.2] 1.0 [0.4–2.4] 1.0 [0.5–2.0]
Past stroke 1,026 (6.5) 15 (7.3) 7 (17.5) 14 (16.7)
0.7 [0.4–1.4] 1.2 [0.4–3.8] 1.9 [0.9–3.9]
OR: odds ratio; 95% CI: 95% confidence interval of the odds ratio. The OR reported were derived from multivariate logistic
regression analyses, with all measured factors forced into the model. The involvement of treating GPs in an educational activity
about depression and self-harm (yes/no) during the follow-up period was also taken into account in the analysis.
Bold print indicates with p< 0.05.
Discussion
The results of this study found a prevalence
of clinically significant anxiety, depression, and
comorbid DA of 4.7%, 1.4%, and 1.8%. About
57% of depression cases showed evidence of
comorbid anxiety, while only 28% of those with
anxiety met criteria for concurrent depression.
There was overlap in the distribution of risk factors
among participants with anxiety, depression, and
comorbid DA, but there were also differences.
For example, the prevalence of clinically significant
anxiety symptoms declined steadily with increasing
age, but the same did not occur for depression.
In addition, some risk factors had opposing effects
on the odds of anxiety and depression: diabetes
was associated with decreased odds of anxiety but
increased odds of depression. The two-year course
of these disorders seemed to differ as well: 31%
of older adults with anxiety at baseline were also
anxious at follow-up, whereas only 23% of those
with depression at baseline displayed the same
symptoms after two years; this figure was 35% for
comorbid DA. Furthermore, repeated anxiety was
more prevalent among women, whereas repeated
depression was more common in men. Participants
with repeated comorbid DA were more frequently
exposed to socioeconomic stressors, such as poor
social support and financial strain.
The relationship between depression and anxiety
in older age is possibly akin to the relationship
that exists between diabetes and hypertension:
these two conditions share numerous risk factors
(e.g., increasing age, obesity, smoking, and physical
inactivity), contribute to similar outcomes (e.g.,
cardiovascular events), and seem to increase the
risk of one another (e.g., more people with than
without diabetes have hypertension) (Fillenbaum
et al., 2000). The interpretation of our results is
also consistent with those from the Longitudinal
Ageing Study Amsterdam (LASA), in which 1,712
participants were followed up every three years
for nine years and the risk factor profiles for
anxiety and depression were found to differ (Vink
et al., 2009). Participants with anxiety at baseline
were at increased risk of subsequently developing
mixed anxiety and depression or repeated anxiety,
but not depression alone. Likewise, a longitudinal
Swedish twin study involving 1,391 participants
(mean age 61 years) found that although anxiety and
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depression were correlated, a model with distinct
anxiety and depression factors fit the data better
than a single mental health factor (Wetherell et al.,
2001).
Our results also show that a large proportion
of older people with pure anxiety and with pure
depression recover over a period of two years,
but those with comorbid anxiety and depression
have a less favorable outcome: most are either
lost to follow-up or remain anxious and depressed.
This suggests that comorbid DA may have a more
chronic and disabling course than either anxiety or
depression alone. Indeed, Cairney and colleagues
reported that older adults with two or more
disorders (depression, social phobia, agoraphobia,
or panic disorder) had greater impairment in
activities of daily living and total number of
disability days than people with no or one mental
disorder (Cairney et al., 2008). These results
are consistent with the possibility that anxiety or
depression precede comorbid DA, which in turn
follows a more chronic course than either condition
alone. If that is the case, then the early successful
management of older adults with “pure” anxiety or
“pure” depression might prove critical to avert such
a development. Our data also suggest that comorbid
DA in later life may demand a more intense and,
perhaps, different treatment approach compared
with pure anxiety or depression.
We had access to a large sample of
community dwelling older adults that was broadly
representative of the Australian community (Pirkis
et al., 2009), although response to invitations
was suboptimal and may have introduced bias as
a result of healthy persons being more willing
to participate (Table S1, available online). The
consequence of such a bias would have been a
reduction in the prevalence of anxiety, depression,
and in the number of people with disabling medical
conditions. We had access to information about
relevant exposures and used accepted approaches
to assess and diagnose clinically significant anxiety
and depression (Zigmond and Snaith, 1983; Spitzer
et al., 1999), but acknowledge that the latter were
not derived from structured clinical interviews or
diagnostic criteria. In addition, the interpretation
of our results needs to take into account the
underlying assumption that the association between
the exposures (risk factors) and outcomes is causal.
There is also the possibility of recall bias, as
people with anxiety and depression may report life
circumstances in a more negative way than people
without either of these conditions. This would
introduce some imprecision in the ascertainment
of the exposures and inflation of their association
with the outcomes, but should not have biased
the “patterns of association” that we found.
Furthermore, given the design of the study, it is
difficult to establish with certainty whether the
association between exposures (risk factors) and
mental health outcomes is causal. Notwithstanding
such a caveat, our analyses indicate that the pattern
of associations (regardless of causality) with anxiety,
depression, and DA is not exactly the same, and
this finding is consistent with the hypothesis that
anxiety and depression in later life are distinct
clinical disorders.
Loss to follow-up can be a significant source
of bias in longitudinal studies, particularly when
outcomes of interest increase the risk of such
a loss (21% in our study). We found that
anxiety, depression, and comorbid DA all increased
the risk of loss to follow-up, and that this
association was particularly strong for participants
showing evidence of comorbidity. Nevertheless,
this differential loss is informative because it
suggests that the course of comorbid anxiety
and depression is different from anxiety without
depression and from depression without anxiety.
Our results are also in line with previous surveys
that reported relatively low prevalence of major
depression in older age (Trollor et al., 2007),
although subsyndromal depression may be more
common and perhaps as disabling (Snowdon,
2001), suggesting that future studies might need
to take such a factor into account. Finally, our data
were derived from a trial of education of general
practitioners (GPs) about depression and self-harm
behavior (Williamson et al., 2007). Data from the
trial showed that the intervention was not associated
with a decline in the prevalence of depression,
although it did reduce suicide ideation (Almeida
et al., 2012). In this study, we found that older
adults treated by GPs assigned for the intervention
had a 10% reduction in the odds of being lost
to follow-up compared with control GPs. For this
reason, we took into account in all analyses the
group assignment of treating GPs to ensure that the
results of this study were not confounded by that
intervention.
In summary, the results of this study indicate
that anxiety and depression have overlapping, but
not identical, risk factor profiles. The presence of
anxiety increases the odds of depression and of
comorbid DA after two years, while the presence
of depression increases the odds of both anxiety
and comorbid DA. Our findings are consistent with
the view that anxiety and depression are separate
disorders that frequently coexist in later life, and
that when they appear together older adults endure
a more chronic, and possibly disabling, course of
illness. Repeated comorbid DA is associated with
various factors, most notably poor social support
and financial strain, which suggests that effective
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psychosocial interventions may be required to
adequately address the needs of this population and
decrease the burden of both anxiety and depression
in later life.
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